These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9189170)

  • 1. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
    Brizel DM; Hage WD; Dodge RK; Munley MT; Piantadosi CA; Dewhirst MW
    Radiat Res; 1997 Jun; 147(6):715-20. PubMed ID: 9189170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ; Saunders MI; Dische S
    Cancer; 1999 Oct; 86(7):1322-8. PubMed ID: 10506720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is hyperbaric oxygen more effective than carbogen/nicotinamide in tumor radiation response?
    Hartmann KA; Van der Kleij AJ; Schneider CJ; Sminia P
    Radiat Res; 1997 Nov; 148(5):523-5. PubMed ID: 9355875
    [No Abstract]   [Full Text] [Related]  

  • 6. Human tumor blood flow is enhanced by nicotinamide and carbogen breathing.
    Powell ME; Hill SA; Saunders MI; Hoskin PJ; Chaplin DJ
    Cancer Res; 1997 Dec; 57(23):5261-4. PubMed ID: 9393746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.
    Brizel DM; Lin S; Johnson JL; Brooks J; Dewhirst MW; Piantadosi CA
    Br J Cancer; 1995 Nov; 72(5):1120-4. PubMed ID: 7577456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors.
    Rodrigues LM; Howe FA; Griffiths JR; Robinson SP
    J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
    Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
    Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
    Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing: dependence on heat dose and tumor type.
    Okajima K; Griffin RJ; Iwata K; Shakil A; Song CW
    Radiat Res; 1998 Mar; 149(3):294-9. PubMed ID: 9496893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H.
    Hartmann KA; van der Kleij AJ; Carl UM; Hulshof MC; Willers R; Sminia P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1037-44. PubMed ID: 11704328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on hyperbaric oxygen and carbogen/nicotinamide with fractionated radiation.
    Brown JM; Wouters BG
    Radiat Res; 1997 Nov; 148(5):526-7. PubMed ID: 9355876
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
    Saunders M; Dische S
    Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors.
    Nöth U; Rodrigues LM; Robinson SP; Jork A; Zimmermann U; Newell B; Griffiths JR
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):909-19. PubMed ID: 15465209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen.
    Song CW; Shakil A; Griffin RJ; Okajima K
    Semin Oncol; 1997 Dec; 24(6):626-32. PubMed ID: 9422259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
    Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
    Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.